Franklin Resources’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.2K Hold
500
﹤0.01% 3094
2025
Q4
$14.5K Hold
500
﹤0.01% 3061
2025
Q3
$13.9K Hold
500
﹤0.01% 3082
2025
Q2
$12.2K Buy
+500
New +$11K ﹤0.01% 2981
2022
Q3
Sell
-872
Closed -$27K 2310
2022
Q2
$27K Buy
872
+216
+33% +$7.55K ﹤0.01% 2290
2022
Q1
$30K Sell
656
-604
-48% -$28.8K ﹤0.01% 2385
2021
Q4
$77K Sell
1,260
-3,295
-72% -$228K ﹤0.01% 2369
2021
Q3
$340K Buy
4,555
+35
+0.8% +$2.94K ﹤0.01% 2038
2021
Q2
$418K Hold
4,520
﹤0.01% 1641
2021
Q1
$401K Buy
4,520
+4,020
+804% +$399K ﹤0.01% 1642
2020
Q4
$47K Buy
+500
New +$39.8K ﹤0.01% 1836

Other funds holding ARKG

Franklin Resources's ARKG Position: Q1 2026 in Review

Franklin Resources held its ARK Genomic Revolution ETF (ARKG) position steady in Q1 2026 at 500 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3094.

Franklin Resources first reported a position in ARKG in Q4 2020 and has held it in 11 quarters since. The position peaked at $418K in Q2 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Franklin Resources held 500 shares of ARK Genomic Revolution ETF worth $13.2K as of Q1 2026.
  • Franklin Resources left its ARK Genomic Revolution ETF share count unchanged in Q1 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #3094 holding.
  • Franklin Resources first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 11 quarters since.
  • Franklin Resources's ARK Genomic Revolution ETF position peaked at $418K in Q2 2021.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.